<?xml version="1.0" encoding="UTF-8"?>
<p id="Par22">There are no FDA-approved therapies for HEV infection, although decreasing immunosuppression appears to have helped control viremia in some chronically infected transplant recipients. In small studies, interferon alpha and ribavirin have been reported to decrease viremia in these patient populations [
 <xref ref-type="bibr" rid="CR72">72</xref>, 
 <xref ref-type="bibr" rid="CR73">73</xref>].
</p>
